Defining optimal immunotherapies for type 1 diabetes. : Novartis Foundation symposium on defining optimal immunotherapies for type 1 diabetes : Jul 2007, London, UK. (Novartis Foundation Symposium ; 292)

Defining optimal immunotherapies for type 1 diabetes. : Novartis Foundation symposium on defining optimal immunotherapies for type 1 diabetes : Jul 2007, London, UK.

(Novartis Foundation Symposium ; 292)

Call No. (NDL): M17-08-1889
Bibliographic ID of National Diet Library: 000009437585

Material type: 図書

Author: -

Publisher: John Wiley & Sons

Publication date: 2008.

Material Format: Paper

Capacity, size, etc.: ix, 212 p. : ill. (some col.) ; 24 cm.

NDC: -

View All

Notes on use

Note (General)：: Papers and discussions.

Search by Bookstore

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Paper

Material Type: 図書
ISBN: 9780470723258
Title: Defining optimal immunotherapies for type 1 diabetes. : Novartis Foundation symposium on defining optimal immunotherapies for type 1 diabetes : Jul 2007, London, UK.
Series Title: Novartis Foundation Symposium ; 292
Publication, Distribution, etc.: Chicester : John Wiley & Sons
Publication Date: 2008.
Publication Date (W3CDTF): 2008
Extent: ix, 212 p. : ill. (some col.) ; 24 cm.
Place of Publication (Country Code): GB
Text Language Code: eng
Subject Heading: Diabetes -- Immunotherapy -- Congresses.
LCC: RC661.I55
DDC: 616.46206
NDLC: M17
Note (General): Papers and discussions.
Note (Bibliography): Includes bibliographical references and indexes.
Holding library: 国立国会図書館
Call No.: M17-08-1889
Data Provider (Database): 国立国会図書館 : 国立国会図書館蔵書
https://ndlsearch.ndl.go.jp
Bibliographic ID (NDL): 000009437585
http://id.ndl.go.jp/bib/000009437585
OCLC No.: 173499055
https://www.worldcat.org/oclc/173499055
Bibliographic Record Category (NDL): 215